RASGEF1C methylation for the distinguishment and classification of benign and malignant thyroid tumors

RASGEF1C methylation for the distinguishment and classification of benign and malignant thyroid tumors

Abstract Background The incidence of thyroid cancer (TC) has significantly increased, highlighting the need for effective and objective approaches for the early diagnosis of TC. This study aimed to explore RASGEF1C methylation as a biomarker for papillary thyroid cancer (PTC). Methods Formalin-fixed...

Full description

Saved in:
Bibliographic Details
Main Authors: Wenkang Yu, Yifei Yin, Mengxia Li, Haixia Huang, Junjie Li, Yi Zhang, Lun Zhu, Yifen Zhang, Xuandong Huang, Chenxia Jiang, Rongxi Yang
Format: Article
Language:English
Published: BMC 2025-07-01
Series:Clinical Epigenetics
Subjects:
Biomarker
DNA methylation
Thyroid cancer
RASGEF1C
Diagnosis
Online Access:https://doi.org/10.1186/s13148-025-01931-y
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s13148-025-01931-y

Similar Items